Oral supramolecular nanovectors for dual natural medicine codelivery to prevent gastric mucosal lesion-Reference-Cited by-同舟云学术

Oral supramolecular nanovectors for dual natural medicine codelivery to prevent gastric mucosal lesion

Published:2022 Issue:25 Volume:14 Page:8967-8977
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Chen Yun¹,Zhang Min¹^ORCID,Zhao Hua¹,Liu Yingju²^ORCID,Wang Tingting³^ORCID,Lei Tingting⁴,Xiang Xiaoyan⁵^ORCID,Lu Luyang⁶,Yuan Ziyi¹,Xu Jingxin¹,Zhang Jingqing¹^ORCID

Affiliation:

1. Chongqing Research Center for Pharmaceutical Engineering, School of Pharmacy, Chongqing Medical University, Chongqing 400016, China

2. Chongqing Key Laboratory of Biochemistry and Molecular Pharmacology, School of Pharmacy, Chongqing Medical University, Chongqing 400016, China

3. Biochemistry and Molecular Biology Laboratory, Experimental Teaching and Management Center, Chongqing Medical University, Chongqing, 400016, China

4. Ningbo Institude for Drug Control, Ningbo 315100, China

5. Department of Pharmacy, People's Hospital of Kaizhou District, Chongqing 405400, China

6. College of Pharmacy, Southwest Minzu University, Chengdu 610041, China

Abstract

Industrializable supramolecular nanovectors loaded with dual natural medicine were orally administered to prevent gastric mucosal lesion. The possible mechanisms were clarified.

Funder

Chongqing Municipal Education Commission

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2022/NR/D2NR01469F

Reference43 articles.

1. Effect of a Cytoprotective Dose of Dehydroleucodine, Xanthatin, and 3-Benzyloxymethyl-5H-furan-2-one on Gastric Mucosal Lesions Induced by Mast Cell Activation

2. Humulene Inhibits Acute Gastric Mucosal Injury by Enhancing Mucosal Integrity